Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026)
Vireo Growth (VREOF) posted Other Operating Expenses of $10.8 million for Q1 2026, down 20.28% sequentially from $13.5 million in Q4 2025, and up 730.77% YoY from $1.3 million in Q1 2025.
Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026) Analysis & Trends
Vireo Growth has reported Other Operating Expenses for 7 years, with the latest figure at $10.8 million in Q1 2026.
- Quarterly Other Operating Expenses rose 730.77% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.1 million (up 443.1% YoY) and the FY2025 annual result came in at $21.9 million, up 900.14% from the prior year.
- Other Operating Expenses retreated to $10.8 million in Q1 2026 per VREOF's latest filing, from $13.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $13.5 million in Q4 2025 and troughed at -$8.6 million in Q4 2022.
- A 5-year average of $2.0 million and a median of $168359.0 in 2022 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 10958.5% in 2023, then soared 49411.94% in 2025.
- Over 5 years, Other Operating Expenses stood at -$8.6 million in 2022, then soared by 94.43% to -$478476.0 in 2023, then jumped by 1515.95% to $6.8 million in 2024, then soared by 99.95% to $13.5 million in 2025, then retreated by 20.28% to $10.8 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $10.8 million, $13.5 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Vireo Growth | 492.80 Mn | 350.50 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.80 Mn |
| Dec 31, 2025 | 13.55 Mn |
| Sep 30, 2025 | 6.09 Mn |
| Jun 30, 2025 | 6.65 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | -12,349.00 |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -887,212.00 |
| Dec 31, 2023 | -478,476.00 |
| Sep 30, 2023 | -823,400.00 |
| Jun 30, 2023 | 719,679.00 |
| Mar 31, 2023 | 386,165.00 |
| Dec 31, 2022 | -8.59 Mn |
| Sep 30, 2022 | 7,583.00 |
| Jun 30, 2022 | -10,930.00 |
| Mar 31, 2022 | 168,359.00 |
| Dec 31, 2021 | 6.47 Mn |
| Mar 31, 2021 | 437,107.00 |
| Dec 31, 2020 | 3.37 Mn |